Comunicación corta
Espironolactona, alternativa terapéutica en el tratamiento de la epiteliopatía difusa crónica
Spironolactone, a therapeutic alternative in the treatment of diffuse retinal pigment epitheliopathy
D. Ángel-Pereira
, P. Rocha-Cabrera, L. Cordovés-Dorta, M.J. Losada Castillo, A. Blasco Alberto, J.A. Abreu Reyes
Autor para correspondencia
Servicio de Oftalmología, Hospital Universitario de Canarias, La Laguna, Tenerife, España
Leído
278
Vecesse ha leído el artículo
57
Total PDF
221
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 2 | 4 | 3 | 7 |
| 2022 5 | 1 | 0 | 1 |
| 2021 4 | 3 | 0 | 3 |
| 2020 12 | 4 | 0 | 4 |
| 2020 11 | 1 | 0 | 1 |
| 2020 6 | 1 | 0 | 1 |
| 2020 2 | 2 | 0 | 2 |
| 2019 10 | 5 | 0 | 5 |
| 2019 2 | 7 | 0 | 7 |
| 2018 9 | 1 | 0 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2018 3 | 2 | 0 | 2 |
| 2018 2 | 21 | 7 | 28 |
| 2018 1 | 5 | 5 | 10 |
| 2017 12 | 10 | 7 | 17 |
| 2017 11 | 21 | 4 | 25 |
| 2017 10 | 27 | 7 | 34 |
| 2017 9 | 28 | 1 | 29 |
| 2017 8 | 13 | 1 | 14 |
| 2017 7 | 7 | 3 | 10 |
| 2017 6 | 18 | 16 | 34 |
| 2017 5 | 4 | 0 | 4 |
| 2017 3 | 2 | 1 | 3 |
| 2017 2 | 5 | 0 | 5 |
| 2016 1 | 7 | 0 | 7 |
| 2016 12 | 21 | 0 | 21 |
| 2016 10 | 0 | 1 | 1 |
| 2016 7 | 0 | 1 | 1 |
Mostrar todo
